Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT06960395 |
| Title | Safety and Preliminary Efficacy of VIR-5525 and VIR-5525 + Pembrolizumab in Participants With Locally Advanced or Metastatic Solid Tumors |
| Recruitment | Recruiting |
| Gender | both |
| Phase | Phase I |
| Variant Requirements | No |
| Sponsors | Vir Biotechnology, Inc. |
| Indications | |
| Therapies | |
| Age Groups: | senior | adult |
| Covered Countries | USA | AUS |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| Honor Health Research Institute | RECRUITING | Scottsdale | Arizona | 85258-4566 | United States | Details |
| MD Anderson | RECRUITING | Houston | Texas | 77030 | United States | Details |
| Wollongong Hospital | RECRUITING | Wollongong | New South Wales | 2500 | Australia | Details |
| Princess Alexandra Hospital | RECRUITING | Woolloongabba | Queensland | 4102 | Australia | Details |